Search Within

Claire Frances Friedman

Formats
  1. Meeting Abstract (60)
  2. Journal Article (55)
  3. Editorial (2)
  4. Book Section (1)
  5. Guidelines (1)
  6. Research Letter (1)
  7. Review (1)
Groups
  1. Department of Medicine (121)
  2. GDMT, Medicine (121)
  3. Gynecologic Medicine Service (121)
  4. Gynecology Disease Management Team (121)
  5. Solid Tumor Oncology Division (121)
  6. Weinberg Fellows (121)

More Groups

People
  1. Carol Aghajanian (44)
  2. Dmitriy Zamarin (41)
  3. Britta Weigelt (32)
  4. Roisin O'Cearbhaill (30)
  5. Nadeem Abu-Rustum (27)
  6. Vicky Makker (26)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (11)
  4. 2022 (29)
  5. 2021 (12)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Gynecologic Oncology (18)
  3. Annals of Oncology (11)
  4. International Journal of Gynecological Cancer (10)
  5. Journal for ImmunoTherapy of Cancer (10)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier B.V. (23)
  3. American Association for Cancer Research (15)
  4. Oxford University Press (14)
  5. Biomed Central Ltd (10)
  6. Lippincott Williams & Wilkins (10)

More Publishers

Results (121)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study
    Meeting Abstract

    Patel, M. R.; Doi, T.; Koyama, T.; Falchook, G. S.; Friedman, C. F.; Piha-Paul, S. A.; Gutierrez, M.; Awad, M. M.; Mattour, A. H.; Satoh, T.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • UPGRADE-A: Phase 1 expansion trial of the NaPi2b-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UpRi) in combination with carboplatin in patients with high-grade serous ovarian cancer (HGSOC)
    Meeting Abstract

    Hays, J. L.; Friedman, C. F.; Lakhani, N.; Anderson, C. K.; Buscema, J.; Duska, L. R.; Hamilton, E. P.; Taylor, S. E.; Carrington, C.; Burger, R. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
    Guidelines

    Disis, M. L.; Adams, S. F.; Bajpai, J.; Butler, M. O.; Curiel, T.; Dodt, S. A.; Doherty, L.; Emens, L. A.; Friedman, C. F.; Gatti-Mays, M.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
    Journal Article

    Rios-Doria, E.; Momeni-Boroujeni, A.; Friedman, C. F.; Selenica, P.; Zhou, Q.; Wu, M.; Marra, A.; Leitao, M. M. Jr; Iasonos, A.; Alektiar, K. M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Comprehensive analysis of germline drivers in endometrial cancer
    Journal Article

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Ranganathan, M.; Green, D.; Aryamvally, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • The search for genomic biomarkers of response to immunotherapy in ovarian cancer
    Editorial

    Al-Rawi, D. H.; Rusk, N.; Friedman, C. F.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer
    Journal Article

    Ashley, C. W.; Selenica, P.; Patel, J.; Wu, M.; Nincevic, J.; Lakhman, Y.; Zhou, Q.; Shah, R. H.; Berger, M. F.; Da Cruz Paula, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: Part 1 results
    Meeting Abstract

    Friedman, C.; Carvajal, R.; Davar, D.; Castanon, E.; Ascierto, P.; Calvo, E.; O'Hara, M.; Powell, S.; Shapira-Frommer, R.; Garralda, E.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save